Koji Yamagata - Concepedia

Author

Koji Yamagata

Also Known As

Koji Yamagata

Publications

128

Citations

H-Index

Concepts

All Affiliations

Koji Yamagata is an author at Pfizer (United States) specializing in drug discovery, medicine, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	128
2	Pharmacology	3	3	128
3	Biochemistry	2	2	52
4	Biomolecular Engineering	1	1	76
5	Neuroscience	1	1	23

Koji Yamagata

Publications

128

Citations

H-Index

Page 1

	Year	Citations
The Synthesis of <i>N</i>-Aryl-5(<i>S</i>)-aminomethyl-2-oxazolidinone Antibacterials and Derivatives in One Step from Aryl Carbamates William R. Perrault, Bruce A. Pearlman, Delara B Godrej, Organic Process Research & Development Medicinal ChemistryDerivativesMedicineAntibacterial AgentAryl Carbamates	2003	76
Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists Paul Galatsis, Koji Yamagata, John A. Wendt, Bioorganic & Medicinal Chemistry Letters Regioisomeric Aryl NaphthyridinesMolecular PharmacologyBiochemistryFunctional SelectivityMedicine	2007	29
Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists Jared B. J. Milbank, Christopher S. Knauer, Corinne E. Augelli‐Szafran, Bioorganic & Medicinal Chemistry Letters BiochemistryFunctional SelectivityRational DesignMedicineRational Drug Design	2007	23

Page 1